FilingPulse

COYA insider transaction filings

Coya Therapeutics, Inc. — 42 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-04-09. Screen COYA transaction legs live →

Insider transaction summary — last 90 days

No Form 4 filings for COYA between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.

Recent Form 4 filings — Coya Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2026-04-094Pavao Mark H — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2026-01-264Grossman Fred — Chief Medical OfficerGrant/award (A): 140,041 (derivative) @ $0EDGAR
2026-01-264Berman Howard — Executive Chairman, DirectorGrant/award (A): 15,257 (derivative) @ $0EDGAR
2026-01-264Swaminathan Arun — Chief Executive Officer, DirectorGrant/award (A): 293,983 (derivative) @ $0EDGAR
2026-01-264SNYDER DAVID S — Chief Financial OfficerGrant/award (A): 140,041 (derivative) @ $0EDGAR
2026-01-064Villalobos Anabella — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2026-01-064Lee Ann — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2026-01-064Weinand Dieter — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2026-01-064GOLDSTEIN DOV A MD — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2026-01-064ROSS WILBUR L JR — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2025-08-194GOLDSTEIN DOV A MD — DirectorOption exercise (M): 17,557 @ $1.09 · Option exercise (M): 17,557 (derivative) @ $0EDGAR
2025-02-254Lee Ann — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2025-02-254Villalobos Anabella — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2025-02-254Weinand Dieter — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2025-02-254GOLDSTEIN DOV A MD — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2025-02-254ROSS WILBUR L JR — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2025-01-134Swaminathan Arun — Chief Executive Officer, DirectorGrant/award (A): 240,964 (derivative) @ $0EDGAR
2025-01-134Grossman Fred — Chief Medical OfficerGrant/award (A): 140,562 (derivative) @ $0EDGAR
2025-01-134Berman Howard — DirectorGrant/award (A): 150,602 (derivative) @ $0EDGAR
2025-01-134SNYDER DAVID S — Chief Financial OfficerGrant/award (A): 140,562 (derivative) @ $0EDGAR
2025-01-034Lee Ann — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2025-01-034Villalobos Anabella — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2025-01-034Weinand Dieter — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2025-01-034GOLDSTEIN DOV A MD — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2025-01-034ROSS WILBUR L JR — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2024-11-144SNYDER DAVID S — Chief Financial OfficerPurchase (P): 1,800 @ $7.19EDGAR
2024-11-134Swaminathan Arun — Chief Executive Officer, DirectorPurchase (P): 5,000 @ $7.36EDGAR
2024-11-124Grossman Fred — Chief Medical OfficerPurchase (P): 2,710 @ $7.37EDGAR
2024-11-124Swaminathan Arun — Chief Executive Officer, DirectorPurchase (P): 5,000 @ $7.34EDGAR
2024-06-054Berman Howard — Chief Executive Officer, DirectorGrant/award (A): 163,663 (derivative) @ $0EDGAR
2024-06-054Grossman Fred — Chief Medical OfficerGrant/award (A): 70,596 (derivative) @ $0EDGAR
2024-06-054SNYDER DAVID S — Chief Financial OfficerGrant/award (A): 70,596 (derivative) @ $0EDGAR
2024-03-054Lee Ann — DirectorPurchase (P): 1,000 @ $3.62EDGAR
2024-02-024Berman Howard — Chief Executive Officer, DirectorGrant/award (A): 189,680 (derivative) @ $0EDGAR
2024-02-024Grossman Fred — Chief Medical OfficerGrant/award (A): 81,819 (derivative) @ $0 · Grant/award (A): 74,069 (derivative) @ $0EDGAR
2024-02-024SNYDER DAVID S — Chief Financial OfficerGrant/award (A): 81,819 (derivative) @ $0EDGAR
2024-01-194Garren Hideki — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2024-01-194Lee Ann — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2024-01-194Villalobos Anabella — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2024-01-194Weinand Dieter — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2024-01-194GOLDSTEIN DOV A MD — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2024-01-044ROSS WILBUR L JR — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR

Recent 8-K events — Coya Therapeutics, Inc.

FiledFormItems reportedSource
2026-09-158-K8.01 — Other EventsEDGAR
2026-08-118-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2026-08-078-K/A5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-06-258-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-128-K2.02 — Results of Operations and Financial Condition
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2026-05-128-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits		EDGAR
2026-04-028-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits		EDGAR
2026-03-168-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2026-01-308-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2026-01-208-K8.01 — Other EventsEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=COYA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →